How a controversial US drug policy could be harming cancer patients worldwide
Abstract
The FDA's accelerated-approval process was designed to help people access life-saving drugs. But gaps in communication could mean that people are undergoing treatments known to be ineffective.
- Publication:
-
Nature
- Pub Date:
- August 2023
- DOI:
- Bibcode:
- 2023Natur.620..264M